Please note that masks must still be worn within NYOH practices regardless of vaccination status.
Learn more about this and other COVID-19 related updates

Clinical Trials & Research

MK-6482 Advanced Renal Cell Carcinoma

MK6482-013: Phase 2 Study of MK-6482 in Participants with Advanced Renal Cell Carcinoma

Disease Types: Renal,&nbs

Available at: {clinical_trial_location backspace="7"}MK-6482 Advanced Renal Cell Carcinoma, {/clinical_trial_location}

Principal Investigator: {clinical_trial_principle_investi} , {/clinical_trial_principle_investi}